Everest Biolabs supplies exosome and EV isolation tools, ELISA kits, and instruments for research in biotech and academic labs.
Everest Biolabs has raised $2.1M in total funding. The most recent round was Grant. The last funding was announced in September 2026.
Everest Biolabs's investors include MassVentures, National Institute of General Medical Science.
Everest Biolabs is headquartered in Waltham, United States.
Everest Biolabs supplies exosome and EV isolation tools, ELISA kits, and instruments for research in biotech and academic labs.
Everest Biolabs is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Everest Biolabs — Funding & Investors." VCBacked, September 24, 2026, https://www.vcbacked.co/company/everest-biolabs. Accessed November 15, 2026.
VCBacked. (2026). Everest Biolabs — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/everest-biolabs
{{cite web |title=Everest Biolabs — Funding & Investors |url=https://www.vcbacked.co/company/everest-biolabs |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Everest Biolabs? Request a listing update